ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2622

Comparison Of Different Methods Of Skin Pathergy Test In Patients With Behçet’s Syndrome

Aysegul Lacin1, Cigdem Atan Uzun1, Zafer Gunendi2 and Feride Gogus1, 1Physical Medicine and Rehabilitation, Division of Rheumatology, Gazi University Faculty of Medicine, Ankara, Turkey, 2Department of Physical Medicine and Rehabilitation, Division of Rheumatology, Gazi University Faculty of Medicine, Ankara, Turkey

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Behcet's syndrome

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Vasculitis III

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Skin pathergy test (SPT) has a diagnostic value in Behçet’s syndrome (BS). There are different descriptions of the test which may effect its positivity rate. We aimed to compare different methods of SPT in patients with Behçet’s syndrome.

Methods:

Patients with BS who fulfilled the International Study Group Criteria for Behçet’s Disease and healthy volunteers were involved in the study. At 90% power (alpha= 0.5) for a 47% positivity rate for the oral method 20 patients and healthy volunteers were recruited (1). Pricks at five different sites were performed with a 20 gauge needle. i)subcutaneous ii) intradermal iii) intradermal with 0.1 cc of 0.09% saline solution iv) intravascular v) oral. The skin pathergy test was considered positive if there was a papule, pustule or oral aphtae (for the oral test) at the prick site after 48 hours. Sensitivity, specificity, positive and negative predictive values of SPT were calculated.

Results:

All patients with Behçet’s syndrome were positive for at least one SPT method where none of the healthy volunteers had a positive SPT. Among the five SPT methods subcutaneous and oral methods were most sensitive (70% and 60% respectively). All SPT methods showed 100% specificity and positive predictive value. Sensitivity and negative predictive values of SPTs are shown in Table 1.

Table 1. Sensitivity and negative predictive value of skin pathergy test methods

Skin Pathergy Methods

Sensitivity

Negative predictive value

Subcutaneous

%70

%77

Oral

%60

%71

Intradermal

%50

%67

Intradermal with saline

%50

%67

Intravascular

%20

%55

Conclusion:

Subcutaneous method is the most sensitive test among SPTs. Oral method may be an alternative for subcutaneous SPT.

Reference:

1. Sharquie KE, Al-Araji A, Hatem A.Oral pathergy test in Behçet’s disease Br J     Dermatol. 2002 Jan;146(1):168-9


Disclosure:

A. Lacin,
None;

C. A. Uzun,
None;

Z. Gunendi,
None;

F. Gogus,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/comparison-of-different-methods-of-skin-pathergy-test-in-patients-with-behcets-syndrome/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology